Table 2

GenBank accession numbers and primer sequences

Gene/primer (GenBank accession number)
Forward
Reverse

GAPDH (NM_002046)
ACCCAGAAGACTGTGGATGG
CAGTGAGCTTCCCGTTCAG
ADAMTS4 (NM_005099)
GGCTACTACTATGTGCTGGAGC
TCCGCACACCATGCACTTGTCA
ADM (NM_001124)
GGATGAAGCTGGTTTCCGTC
GACTCAGAGCCCACTTATTC
ADFP (NM_001122)
GTTGCCAATACCTATGCCTG
CAGTAGTCGTCACAGCATCT
CD14 (NM_000591)
GAGGTTCGGAAGACTTATCG
ATCTTCATCGTCCAGCTCAC
COL4A1 (NM_001845)
TAGAGAGGAGCGAGATGTTC
GTGACATTAGCTGAGTCAGG
CTNNB1 (NM_001904)
GGTGCTATCTGTCTGCTCTAGT
GACGTTGACTTGGATCTGTCAGG
FST (NM_006350)
GGCAAGATGTAAAGAGCAGC
CATTATTGGTCTGGTCCACC
GADD45B (NM_015675)
TTGCAACATGACGCTGGAAG
CATTCATCAACTTGGCCGAC
IBSP (NM_004967)
CAATCCAGCTTCCCAAGAAG
CTTCTGCTTCGCTTTCTTCG
INHBA (NM_002192)
GAACTTATGGAGCAGACCTC
TGCCTTCCTTGGAAATCTCG
INSIG1 (NM_005542)
TGTATCGACAGTCACCTCGGA
GGACAGCTGGACATTATTGGC
ITGB2 (NM_000211))
AAGTGACGCTTTACCTGCGA
CCTGAGGTCATCAAGCATGG
KLF6 (NM_001300)
TGTGCAGCATCTTCCAGGAG
AACGTTCCAGCTCTAGGCAG
MEPE (NM_020203)
GCAAAGCTGTGTGGAAGAGCAGA
CCCTTATTCTCACTGGCTTCAG
MMP25 (NM_004142)
ATGTCACCGTCAGCAACGCA
CGGTCTTGATGCTGTTCTTG
MT2A (NM_005953)
GCAAATGCACCTCCTGCAAG
GTGGAAGTCGCGTTCTTTAC
NHERF1 (NM_004252)
TCACCAATGGGGAGATACAG
GTCTTGGGAATTCAGCTCCT
PTEN (NM_000314)
AAGACAAAGCCAACCGATAC
GAAGTTGAACTGCTAGCCTC
RUNX2 (NM_004348)
TGATGACACTGCCACCTCTG
GGGATGAAATGCTTGGGAAC
S100A4 (NM_002961)
GTCAGAACTAAAGGAGCTGC
TGTTGCTGTCCAAGTTGCTC
SMAD3 (NM_005902)
TTCAACAACCAGGAGTTCGC
TACTGGTCACAGTA
STC1 (NM_003155)
CCTGTGACACAGATGGGATG
GAATGGCGAGGAAGACCTTG
TIMP4 (NM_003256)
TTGACTGGTCAGGTCCTCAGT
GGTACTGTGTAGCAGGTGGT
TWIST1 (NM_000474)
TCAGCAGGGCCGGAGACCTAGAT
GTCTGGGAATCACTGTCCAC
WNT5B (AY009399)
ACCCTACTCTGGAAACTGTC
TAAACATCTCGGGTCTCTGC

'Slide' indicates the microarray slide comparison. Slides 1 to 10 are control (CTL)-osteoarthritis (OA) female sample pairs, slides 11 to 20 are CTL-OA male sample pairs, slides 21 to 30 are OA-osteoporosis (OP) female sample pairs and slides 32 to 40 are CTL-OP female sample pairs. GEO, Gene Expression Omnibus; ID, individual/sample.

Hopwood et al. Arthritis Research & Therapy 2007 9:R100   doi:10.1186/ar2301